Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 80 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Post Approval Study for Treatment of Drug-resistant Adult Primary FSGS Using the LIPOSORBER® LA-15 System

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

    Rochester, MN

  3. Artisan Aphakia Lens for the Correction of Aphakia in Children

    Rochester, MN

  4. Testicular Tissue Cryopreservation in Children

    Rochester, MN

  5. A Study to Analyze Surgical Outcomes and Predictors of Treatment for Hip Diseases

    Rochester, MN

  6. A Study Measuring the Effectiveness of Simulated Preparation for Commonly Encountered Emotional, Cultural and Medical Difficulties in Global Health Experiences

    Rochester, MN

  7. To Assess the Effectiveness, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva

    Rochester, MN

  8. Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors

    Scottsdale/Phoenix, AZ

  9. Accelerated vs Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

    Rochester, MN

  10. Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

    Rochester, MN

.

Mayo Clinic Footer